EN | UA
EN | UA

Help Support

Back

Study compares bismuth-based quadruple vs metronidazole-intensified triple therapy for H. pylori infection

H.pylori_infection H.pylori_infection
H.pylori_infection H.pylori_infection

What's new?

In comparison with metronidazole-intensified triple therapy, bismuth-based quadruple therapy is highly cost-effective with similar efficacy in H. pylori patients.

In an open-label, multicenter, randomized controlled trial published in Gut Liver, a 14-day bismuth-based quadruple therapy (BQT) demonstrated comparable efficacy and more cost-effectiveness when compared to 14-day metronidazole-intensified triple therapy (MIT) for people diagnosed with clarithromycin-resistant Helicobacter pylori (H. pylori) infection with genotypic resistance.

Researchers undertook this study to assess the cost-effectiveness and efficacy of two therapies for the management of H. pylori infection. Utilizing sequencing-based clarithromycin resistance point mutation tests, examination of H. pylori-infected people was done. Overall, 782 volunteers with profound point mutations (A2144G, A2142C, A2143G, A2142G, A2143C) were randomized to get either MIT (n=99) or BQT (n=102).

The overall genotypic clarithromycin resistance rate was found to be 25.7%. The H. pylori elimination rate of BQT was not considerably distinct in the intention-to-treat analysis. However, it was remarkably greater when compared to MIT in the per-protocol analysis, as shown in Table 1:

No profound differences were noted in the occurrence of adverse effects. Furthermore, compared to MIT, BQT was found to be more cost-effective. Thus, BQT and MIT show comparable effectiveness as first-line therapy for H. pylori infection with genotypic clarithromycin resistance.

 

Source:

Gut Liver

Article:

Bismuth-Based Quadruple Therapy versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial

Authors:

Seung In Seo et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: